<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03503682</url>
  </required_header>
  <id_info>
    <org_study_id>RT-15-06 SHARON BONE</org_study_id>
    <nct_id>NCT03503682</nct_id>
  </id_info>
  <brief_title>Short Course Radiation Therapy in Palliative Treatment of Complicated Bone Metastases</brief_title>
  <official_title>SHort Course Accelerated RadiatiON Therapy (SHARON) in Complicated Bone Metastases Palliation: an Interventional, Randomised, Multicentric Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of the study is to assess efficacy of a short course radiation treatment in patients with
      complicated bone metastases
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Standard treatment for complicated bone metastases (3000 cGy in 10 daily fractions of 300 cGy
      each) is compared with experimental treatment (4000 cGy in 4 fractions of 500 cGy twice a
      day) to demonstrate non-inferiority of this scheme.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 8, 2017</start_date>
  <completion_date type="Anticipated">November 8, 2023</completion_date>
  <primary_completion_date type="Anticipated">November 8, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of palliation using the short course scheme compared with the standard scheme</measure>
    <time_frame>3 months</time_frame>
    <description>Reduction of pain after radiotherapy, assessed with VAS (visual analogue scale)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Acute toxicity in the two treatment groups</measure>
    <time_frame>3 months</time_frame>
    <description>incidence of treatment-related acute adverse events in the two arms of the study registered using Cooperative Group Common Toxicity Criteria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late toxicity in the two treatment groups</measure>
    <time_frame>12 months</time_frame>
    <description>incidence of treatment-related late adverse events in the two arms of the study registered using RTOG/EORTC Late Radiation Morbidity Scoring Schema</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life (QoL) assessment in the two groups</measure>
    <time_frame>12 months</time_frame>
    <description>Changes in QoL after the treatment assessed using EORTC questionnaires (QLQ-BM22 and C15-PAL)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">82</enrollment>
  <condition>Bone Metastases</condition>
  <condition>Radiotherapy</condition>
  <condition>Palliative Care</condition>
  <arm_group>
    <arm_group_label>standard treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this group are treated with 3000 cGy in 10 daily fractions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>short course treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this group are treated with 2000 cGy in 4 fractions administered twice a day (at least 6-8 hours interval)</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>standard treatment</intervention_name>
    <description>3000 cGy in 10 daily fractions</description>
    <arm_group_label>standard treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>short course treatment</intervention_name>
    <description>2000 cGy in 4 fractions administered twice a day</description>
    <arm_group_label>short course treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  complicated bone metastases from any solid tumor

          -  age &gt;18 years

          -  ECOG performance status 0-3

          -  symptomatic lesion (NRS &gt;1)

          -  no changes in analgesic treatment at least in the week before radiotherapy

        Exclusion Criteria:

          -  pregnancy

          -  previously irradiation of the same region
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alessio G Morganti, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radiation Oncology Center, Department of Experimental, Diagnostic and Speciality Medicine-DIMES, Unversity of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alessio G Morganti, MD</last_name>
    <phone>0512143564</phone>
    <phone_ext>+39</phone_ext>
    <email>alessio.morganti2@unibo.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Radiation Oncology Center, Department of Experimental, Diagnostic and Speciality Medicine- DIMES, University of Bologna, S.Orsola-Malpighi Hospital</name>
      <address>
        <city>Bologna</city>
        <state>BO</state>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alessio G Morganti, MD</last_name>
      <phone>0512143564</phone>
      <phone_ext>+39</phone_ext>
      <email>alessio.morganti2@unibo.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 9, 2018</study_first_submitted>
  <study_first_submitted_qc>April 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 20, 2018</study_first_posted>
  <last_update_submitted>April 19, 2018</last_update_submitted>
  <last_update_submitted_qc>April 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi</investigator_affiliation>
    <investigator_full_name>Alessio Giuseppe Morganti</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Short Course Radiotherapy</keyword>
  <keyword>Complicated Bone Metastases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Neoplasms, Second Primary</mesh_term>
    <mesh_term>Bone Neoplasms</mesh_term>
    <mesh_term>Bone Marrow Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

